A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology.
Patient-derived tumor xenograft (PDX)/organoid (PDO), driven by cancer stem cells (CSC), are considered the most predictive models for translational oncology. Large PDX collections reflective of patient populations have been created and used extensively to test various investigational therapies, inc...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Public Library of Science (PLoS)
2023-01-01
|
丛编: | PLoS ONE |
在线阅读: | https://doi.org/10.1371/journal.pone.0279821 |